Monolithic Trading

[greenwillow]

Plasma treatment being tested in New York may be coronavirus 'game changer'
Conor Ferguson and Cynthia McFadden and Didi Martinez
NBC NewsApril 7, 2020, 5:31 PM EDT


https://www.yahoo.com/news/plasma-treatment-being-tested-york-213100838.html

Watching ADMA - ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical trials for the treatment of primary immune deficiency disease. The company also offers Nabi-HB, a hyperimmune globulin for the treatment of acute exposure; and Bivigam, an intravenous immune globulin for the treatment of primary humoral immunodeficiency. In addition, it operates source plasma collection facilities in Norcross, Marietta, and Kennesaw, Georgia. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.